Patients with renal involvement had significantly higher MPO-ANCA titers at lung disease onset (82 UI/mL, IQR 20.8–382) when compared to patients without renal impairment (9.6 UI/mL, IQR 4.6–42.8) (p = 0.016) (Fig. 3). This evidence concerns the gene MPO and lung disorder.